Anika Therapeutics ANIK

$ 17.0 -2.47%

Quarterly report 2024-Q3
added 11-04-2024

Anika Therapeutics Financial Statements 2011-2024 | ANIK

Annual Financial Statements Anika Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	373 M	406 M	458 M	526 M	606 M	548 M	994 M	730 M	562 M	575 M	472 M	141 M	119 M
Shares	14.7 M	14.6 M	14.4 M	14.2 M	14.1 M	14.4 M	14.6 M	14.7 M	14.9 M	14.7 M	14.1 M	13.3 M	13.1 M
Historical Prices	25.4	27.9	31.8	37	41.1	38	66.7	50.5	37.6	39.2	33.3	10.6	9.2
Net Income	-82.7 M	-14.9 M	4.13 M	-24 M	27.2 M	18.7 M	31.8 M	32.5 M	30.8 M	38.3 M	20.6 M	11.8 M	8.47 M
Revenue	167 M	156 M	148 M	130 M	115 M	106 M	113 M	103 M	93 M	106 M	75.1 M	71.4 M	64.8 M
Cost of Revenue	63.6 M	62.7 M	64.9 M	61.4 M	28.7 M	31.3 M	27.4 M	24 M	-	-	-	-	-
Gross Profit	103 M	93.6 M	82.9 M	69 M	85.9 M	74.3 M	86.1 M	79.4 M	71.9 M	84.7 M	52.3 M	42.4 M	38 M
Operating Income	-87.6 M	-19.4 M	2.62 M	-28.3 M	34.2 M	21.7 M	45.7 M	50.6 M	48.1 M	61.4 M	32.6 M	19.7 M	14 M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-81.2 M	-12.7 M	9.1 M	-22.2 M	40.2 M	27.7 M	50 M	54.3 M	51.9 M	66.2 M	37.1 M	26.8 M	18 M
Operating Expenses	-	-	-	-	51.6 M	52.5 M	40.3 M	28.7 M	23.8 M	23.2 M	20 M	20.1 M	24 M
General and Administrative Expenses	95.8 M	84.8 M	74.1 M	60.1 M	35 M	34.3 M	21.5 M	18 M	14.8 M	15.1 M	12.9 M	14.7 M	17.9 M

All numbers in USD currency

Quarterly Income Statement Anika Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	14.8 M	14.8 M	14.7 M	14.7 M	14.6 M	14.7 M	14.7 M	14.6 M	14.6 M	14.6 M	14.5 M	14.4 M	14.4 M	14.4 M	14.3 M	14.3 M	14.2 M	14.2 M	14.2 M	14.3 M	14.1 M	13.9 M	14.2 M	14.2 M	14.2 M	14.7 M	14.7 M	14.7 M	14.6 M	14.6 M	14.6 M	14.6 M	14.6 M	14.7 M	14.9 M	15 M	15 M	15 M	14.9 M	14.9 M	14.8 M	14.7 M	14.5 M	14.3 M	13.7 M	13.5 M	13.4 M	13.3 M	13.3 M	13.3 M	13.2 M	13.1 M	12.8 M	12.7 M	12.7 M
Net Income	-29.9 M	-88 K	-4.51 M	-	-6.58 M	-2.74 M	-10.4 M	-	-4.18 M	-2.84 M	-2.93 M	-	558 K	6.53 M	2.84 M	-15.7 M	-6.41 M	-7.71 M	5.79 M	4.05 M	9.2 M	9.44 M	4.51 M	7.72 M	7.6 M	10.1 M	-6.69 M	8.07 M	6.89 M	11.4 M	5.49 M	8.08 M	8.95 M	8.62 M	6.9 M	11 M	8.38 M	7.82 M	3.52 M	7.82 M	6.17 M	9.3 M	15 M	6.65 M	4.96 M	5.89 M	3.07 M	4.46 M	1.65 M	3.74 M	1.91 M	2.88 M	2.98 M	2.28 M	324 K
Revenue	38.8 M	41.9 M	40.5 M	-	41.5 M	44.3 M	37.9 M	-	40.3 M	39.7 M	36.7 M	-	39.5 M	38.1 M	34.3 M	32.7 M	31.7 M	30.7 M	35.4 M	29.8 M	29.7 M	30.4 M	24.7 M	27 M	26.8 M	30.5 M	21.3 M	29.4 M	27.2 M	33.5 M	23.4 M	28.7 M	25.8 M	26.6 M	22.3 M	30.9 M	23.7 M	22.9 M	15.5 M	23.3 M	22.1 M	26.3 M	34 M	21.3 M	17.8 M	20.8 M	15.2 M	22.6 M	14.8 M	19.6 M	14.4 M	18.4 M	18.5 M	16.1 M	11.7 M
Cost of Revenue	37.3 M	14.6 M	15.9 M	-	16.5 M	15.3 M	15.1 M	-	17.5 M	14.8 M	14.9 M	-	16.5 M	17.3 M	13.3 M	-	14.4 M	16.9 M	14.2 M	8.65 M	5.95 M	6.84 M	7.31 M	7 M	8.28 M	8.15 M	7.84 M	8.72 M	6.25 M	6.32 M	6.08 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	1.44 M	27.4 M	24.6 M	-	24.9 M	29 M	22.8 M	-	22.8 M	24.9 M	21.8 M	-	23 M	20.8 M	21 M	16.7 M	17.3 M	13.7 M	21.2 M	21.1 M	23.7 M	23.6 M	17.4 M	19.9 M	18.5 M	22.4 M	13.4 M	20.2 M	20.9 M	22 M	17.3 M	20.8 M	20.8 M	20.5 M	16.9 M	19.3 M	18.5 M	17.6 M	11.2 M	12.4 M	16.2 M	15.9 M	9.99 M	14 M	11.6 M	13.8 M	9.65 M	14.2 M	6.83 M	10.8 M	7.2 M	10.6 M	10.4 M	8.76 M	5.46 M
Operating Income	-28 M	161 K	-5.06 M	-	-7.67 M	-3.63 M	-12.6 M	-	-5.8 M	-3.38 M	-3.55 M	-	1.3 M	9.18 M	1.26 M	-	-7.93 M	-9.54 M	7.09 M	-	12 M	11.9 M	5.48 M	-	8.57 M	11.2 M	-7.83 M	-	10.3 M	17.7 M	8.01 M	-	13.7 M	13.5 M	10.7 M	-	13.1 M	12.4 M	5.5 M	-	10.3 M	15.2 M	23.9 M	-	7.77 M	9.4 M	5.01 M	-	2.73 M	6.13 M	3.06 M	-	4.82 M	3.68 M	557 K
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-27.7 M	561 K	-3.33 M	-	-5.77 M	-1.63 M	-10.9 M	-	-814 K	-1.48 M	-1.88 M	-	6 M	11.2 M	2.8 M	-	-3.38 M	-3.08 M	9.86 M	-	16.5 M	14.9 M	6.96 M	-	13 M	14.2 M	-6.36 M	-	13.5 M	19.7 M	9.02 M	-	16.5 M	15.4 M	11.7 M	-	15.9 M	14.3 M	6.42 M	-	13.9 M	17.6 M	25.1 M	-	11.3 M	11.7 M	6.21 M	-	6.09 M	8.32 M	4.05 M	-	7.76 M	5.62 M	1.48 M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	19.1 M	19.8 M	21.5 M	-	24.8 M	23.7 M	27 M	-	21.3 M	21.3 M	19.2 M	-	17.5 M	18 M	18.2 M	-	15.9 M	14.6 M	14.4 M	-	7.54 M	7.5 M	7.67 M	-	5.7 M	6.42 M	16.1 M	-	4.82 M	4.97 M	5.07 M	-	4.28 M	4.26 M	3.99 M	-	3.31 M	3.39 M	3.6 M	-	4.04 M	3.87 M	3.49 M	-	3.19 M	3.4 M	3.95 M	-	3.6 M	4.11 M	3.35 M	-	4.71 M	4.23 M	4.04 M

All numbers in USD currency